Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy.
AffiliationUniversity Department of Dermatology, Western Infirmary, Glasgow G11 6NT, UK. email@example.com
MetadataShow full item record
AbstractBACKGROUND: A variety of protocols exist for the treatment of Bowen's disease by photodynamic therapy (PDT) using topical 5-aminolaevulinic acid (5-ALA). OBJECTIVE: To determine the optimal wavelength (red or green light) for this treatment. METHODS: A randomized comparison study of ALA-PDT using red (630 +/- 15 nm) or green (540 +/- 15 nm) light in the treatment of Bowen's disease. RESULTS: The initial clearance rate for lesions treated by red light was 94% (30 of 32) in comparison with 72% (21 of 29) for those lesions receiving green light (P = 0.002). Over the following 12 months, there were two recurrences in the red light group and seven in the green light group reducing the clearance rates to 88% and 48%, respectively. The frequency and severity of pain experienced were similar between the two treatment groups. No hyperthermia, nor significant difference in lesional temperatures, was observed between the wavelengths studied. CONCLUSION: Green light is less effective than red light, at a theoretically equivalent dose, in the treatment of Bowen's disease by topical ALA-PDT.
CitationComparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. 2000, 143 (4):767-72 Br. J. Dermatol.
JournalThe British Journal of Dermatology
- Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy.
- Authors: Britton JE, Goulden V, Stables G, Stringer M, Sheehan-Dare R
- Issue date: 2005 Oct
- Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma.
- Authors: Dijkstra AT, Majoie IM, van Dongen JW, van Weelden H, van Vloten WA
- Issue date: 2001 Nov
- Long-term recurrence of nonmelanoma skin cancer after topical methylaminolevulinate photodynamic therapy in a dermato-oncology department.
- Authors: Cabete J, Rafael M, Cravo M, Moura C, Sachse F, Pecegueiro M
- Issue date: 2015 Nov-Dec
- Interventions for cutaneous Bowen's disease.
- Authors: Bath-Hextall FJ, Matin RN, Wilkinson D, Leonardi-Bee J
- Issue date: 2013 Jun 24
- Efficacy of photodynamic therapy with topical 5-aminolevulinic acid using intense pulsed light for Bowen's disease.
- Authors: Hasegawa T, Suga Y, Mizuno Y, Haruna K, Ogawa H, Ikeda S
- Issue date: 2010 Jul